ArticleAmerican journal of clinical oncology2020

Survival Outcomes After Adding Stereotactic Body Radiotherapy to Metastatic Renal Cell Carcinoma Patients Treated With Tyrosine Kinase Inhibitors.

Liru He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.